Ondansetron injection, 2 mg/mL is a clear, colorless, nonpyrogenic, sterile solution available as a 2 mL single dose vial and 20 mL multiple dose vial
Ondansetron is in a class of medications called serotonin 5-HT 3 receptor antagonists
30 minutes before the start of moderately to highly emetogenic chemotherapy
ZOFRAN is a 5-HT3 receptor antagonist indicated for the prevention of: nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m2
dosage of ZOFRAN for pediatric patients (2 to 12 years of age) is a single 0
If additional glycemic control is needed after at least 4 weeks receiving 0
GERD: Mild liver dysfunction (Child-Pugh A): 10 to 15 mg orally 4 times a day (30 minutes before each meal and at bedtime) Maximum dose: 60 mg/day
If these effects last or get worse, tell Store between 2° and 30°C (36° and 86°F)
The usual duration of administration is 7 to
A headache, hypoxia, and fever are some of the more commonly reported side effects
, anaphylaxis) to this product or any of its components
Ondansetron Injection, USP is indicated for the prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including high-dose cisplatin
The adverse event profiles in children and adolescents were comparable to that seen in adults
Depending on the route of administration, dosage forms come in several different types
Table 1: Recommended Dosage of ALOXI Injection for the Prevention of Nausea and Vomiting Associated with Chemotherapy in Adults and Pediatric Patients 1 Month to Less than 17 Years
FDA does not anticipate that removal of the 32 mg intravenous dose of ondansetron currently sold as pre-mixed injections will contribute to a drug shortage of IV ondansetron, as the 32 mg dose